Cargando…
Two cases of nintedanib-induced diarrhoea treated using a 5-hydroxytryptamine type 3 receptor antagonist
Nintedanib-induced diarrhoea may be controlled by ramosetron by modulation of intestinal motility as for irritable bowel syndrome #pulmonaryfibrosis https://bit.ly/3OQVAII
Autores principales: | Arai, Toru, Inoue, Yoshikazu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511131/ https://www.ncbi.nlm.nih.gov/pubmed/36171988 http://dx.doi.org/10.1183/23120541.00242-2022 |
Ejemplares similares
-
Association of 5-Hydroxytryptamine 3 Receptor Antagonists With the Prognosis of Liver Failure
por: Chen, Yuting, et al.
Publicado: (2021) -
Effective treatment with combination of peripheral 5‐hydroxytryptamine synthetic inhibitor and 5‐hydroxytryptamine 2 receptor antagonist on glucocorticoid‐induced whole‐body insulin resistance with hyperglycemia
por: Ma, Shaoxin, et al.
Publicado: (2016) -
The anti-emetic potential of the 5-hydroxytryptamine3 receptor antagonist BRL 43694.
por: Bermudez, J., et al.
Publicado: (1988) -
5- Hydroxytryptamine
por: Giarman, Nicholas J.
Publicado: (1958) -
The impact of 5-hydroxytryptamine-receptor antagonists on chemotherapy treatment adherence, treatment delay, and nausea and vomiting
por: Palli, Swetha Rao, et al.
Publicado: (2015)